Dena Battle

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

Brian I. Rini, Dena Battle, Robert A. Figlin et al. · Journal for ImmunoTherapy of Cancer · 2019 · 262 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

Mohamad E. Allaf, Se-Eun Kim, Viraj A. Master et al. · The Lancet Oncology · 2024 · 82 citations · Full text

Medicine, Oncology, Surgery +10

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement

Gennady Bratslavsky, Neil Mendhiratta, Michael Daneshvar et al. · Cancer · 2021 · 46 citations · Full text

Life Sciences, Genetics, Oncology +17

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

Cristiane Decat Bergerot, Errol J. Philip, Paulo Gustavo Bergerot et al. · Cancer · 2020 · 38 citations · Full text

Pharmacy, Oncology, Cancer Symptom Management +16

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

Cristiane Decat Bergerot, Dena Battle, Errol J. Philip et al. · JCO Oncology Practice · 2020 · 27 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16